| Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 3 Feb 25 | BK The Bank of New York Mellon Corporation | Common Stock | Grant | Acquire A | No | No | 85.19 | 880.305 | 74.99 k | 60,070.93 |
| 31 Dec 24 | PFE Pfizer | Phantom Stock Units Common Stock | Grant | Acquire A | No | No | 26.53 | 1,743.309 | 46.25 k | 123,639.287 |
| 1 Oct 24 | BK The Bank of New York Mellon Corporation | Common Stock | Grant | Acquire A | No | No | 71.11 | 1,054.704 | 75.00 k | 58,825.921 |
| 30 Sep 24 | PFE Pfizer | Phantom Stock Units Common Stock | Grant | Acquire A | No | No | 28.94 | 1,598.134 | 46.25 k | 119,944.9 |
| 1 Jul 24 | BK The Bank of New York Mellon Corporation | Common Stock | Grant | Acquire A | No | No | 60.11 | 1,247.713 | 75.00 k | 57,347.754 |
